CONTEXT: Neuroradiology fellow Dr. Roula Hourani at Johns Hopkins University researched the ability of proton MR spectroscopy (MRS) to differentiate between benign brain neoplasia and tumors in children. Potentially, such a non-invasive diagnostic approach would most benefit children with non-neoplastic lesions and less accessible tumors that could be treated by radio- or chemotherapy.
CONTEXT: Neuroradiology fellow Dr. Roula Hourani at Johns Hopkins University researched the ability of proton MR spectroscopy (MRS) to differentiate between benign brain neoplasia and tumors in children. Potentially, such a non-invasive diagnostic approach would most benefit children with non-neoplastic lesions and less accessible tumors that could be treated by radio- or chemotherapy.
RESULTS: MRI and high-resolution multislice proton MRS (three to four 15-mm slices separated by 2.5 mm) were performed on 36 children with primary brain lesions on a 1.5T scanner using a standard birdcage head coil. Resolution of 0.8-mL voxel size was the same in all experiments. MRS provided data on choline (Cho) and creatine (Cr), revealing that tumors and non-neoplastic lesions could be distinguished by differences in the Cho/Cr ratio, with tumors having a higher Cho/Cr ratio.
IMAGE: Comparison of proton MR spectra of a benign thalamic lesion (A: acute disseminated encephalomyelitis, nine-year-old female) and a tumor (B: pilocytic astrocytoma, 12-year-old male). A higher Cho/Cr ratio was detected in the tumor (Cho/Cr = 2.03) than in the benign lesion (Cho/Cr = 0.80).
IMPLICATIONS: This is the first study to apply multislice MRS sequences to differentiate nonneoplastic lesions from tumors in children. The study provides preliminary data that proton MRS can help evaluate pediatric brain lesions. The approach holds the most promise in identifying inaccessible and benign lesions (avoiding the need for biopsy). The next step in this work is a prospective study combining spectroscopy with other MRI techniques, such as perfusion, according to researcher Alena Horska, Ph.D, an assistant professor of radiology at Johns Hopkins.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.